MTSR Metsera Inc

Exhibit 1

 

AGREEMENT OF JOINT FILING

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Metsera, Inc.

 

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.

 

Date:   February 10, 2025

 

ARCH VENTURE FUND XII, L.P.

 

By:    ARCH Venture Partners XII, L.P.

its General Partner

 

By:    ARCH Venture Partners XII, LLC

its General Partner

 

By:                  *                            

Robert Nelsen 

Managing Director

 

 

ARCH VENTURE PARTNERS XII, L.P.

 

By:  ARCH Venture Partners XII, LLC

its General Partner

 

By:                  *                             

Robert Nelsen 

Managing Director

 

 

ARCH VENTURE PARTNERS XII, LLC

 

By:                   *                             

Robert Nelsen

Managing Director

 

 

ARCH VENTURE PARTNERS XII, LLC

 

By:                   *                             

Robert Nelsen

Managing Director

 

 

 

                          *                             

Keith Crandell

 

                          *                             

Robert Nelsen

 

                          *                             

Kristina Burow

 

                          *                             

Steven Gillis

 

* By:  /s/ Mark McDonnell            

Mark McDonnell as

Attorney-in-Fact

 

 

*          This Agreement of Joint Filing was executed by Mark McDonnell pursuant to a Powers of Attorney filed as Exhibit 24 and 24.1 to the Form 3 relating to the beneficial ownership of shares of Neumora Therapeutics, Inc. by the Reporting Persons filed with the Securities Exchange Commission on September 14, 2023 and incorporated herein in its entirety by reference.

 

 

EXHIBIT 2

 

 

AGREEMENT OF JOINT FILING

 

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Prime Medicine, Inc.

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.

 

Date:        February 10, 2025

 

ARCH VENTURE FUND XIII, L.P.

 

By:    ARCH Venture Partners XIII, L.P.

its General Partner

 

By:    ARCH Venture Partners XIII, LLC

its General Partner

 

By:                  *                            

Keith Crandell 

Managing Director

 

 

ARCH VENTURE PARTNERS XIII, L.P.

 

By:  ARCH Venture Partners XIII, LLC

its General Partner

 

By:                  *                             

Keith Crandell 

Managing Director

 

 

ARCH VENTURE PARTNERS XIII, LLC

 

By:                   *                             

Keith Crandell

Managing Director

 

 

 

 

                          *                             

Keith Crandell

 

                          *                             

Robert Nelsen

 

                          *                             

Kristina Burow

  

                          *                             

Paul Berns

 

* By:  /s/ Mark McDonnell            

Mark McDonnell as

Attorney-in-Fact

 

 

*          This Agreement of Joint Filing was executed by Mark McDonnell pursuant to a Power of Attorney filed as Exhibit 24.1 to the Form 3 relating to the beneficial ownership of shares of Metsera, Inc. by the Reporting Persons filed with the Securities Exchange Commission on January 30, 2025 and incorporated herein in its entirety by reference.

 

---